tagraxofusp for r/r myelofibrosis shows promise
Published 4 years ago • 150 plays • Length 2:17Download video MP4
Download video MP3
Similar videos
-
2:43
phase i/ii trial of tagraxofusp in poor-risk myelofibrosis
-
4:39
imetelstat shows promise in advanced myelofibrosis
-
1:18
novel approaches for the treatment of myelofibrosis: navitoclax ruxolitinib
-
5:12
ongoing clinical trials of ruxolitinib-based combinations in myelofibrosis
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
21:38
drawing the line: the rationale behind blood tube collection order
-
2:44
myelofibrosis: jenson shares his experience
-
3:19
first-line treatment selection in myelofibrosis
-
1:31
promising agents under investigation for the treatment of myelofibrosis with cytopenia
-
1:38
pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
-
1:58
novel myelofibrosis-associated anemia treatments in phase ii trials
-
3:44
phase ii study update of navtemadlin in patients with myelofibrosis r/r to ruxolitinib
-
8:03
phase ii trial of navitoclax and ruxolitinib in high-risk r/r myelofibrosis
-
1:01
latest advances in myelofibrosis treatment
-
1:16
the rationale for combining magrolimab with ruxolitinib in myelofibrosis
-
0:52
rilzabrutinib: a novel promising btk inhibitor being explored in itp
-
2:54
ruxolitinib in the real world: myelofibrosis
-
1:15
ongoing trials of ruxolitinib, momelotinib and imetelstat in myelofibrosis
-
1:34
pelabresib in myelofibrosis: the manifest trials
-
1:45
design and results of pacritinib for myelofibrosis trial (persist-1)
-
1:39
refine: updated data on navitoclax and ruxolitinib for myelofibrosis